89 related articles for article (PubMed ID: 17064702)
1. Identification of potential therapeutic targets by gene-expression profiling in pancreatic endocrine tumors.
Couvelard A; Hu J; Steers G; O'Toole D; Sauvanet A; Belghiti J; Bedossa P; Gatter K; Ruszniewski P; Pezzella F
Gastroenterology; 2006 Nov; 131(5):1597-610. PubMed ID: 17064702
[TBL] [Abstract][Full Text] [Related]
2. Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
Hansel DE; Rahman A; House M; Ashfaq R; Berg K; Yeo CJ; Maitra A
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6152-8. PubMed ID: 15448002
[TBL] [Abstract][Full Text] [Related]
3. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
[TBL] [Abstract][Full Text] [Related]
4. Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays.
Maitra A; Hansel DE; Argani P; Ashfaq R; Rahman A; Naji A; Deng S; Geradts J; Hawthorne L; House MG; Yeo CJ
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5988-95. PubMed ID: 14676124
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
6. RUNX1T1: a novel predictor of liver metastasis in primary pancreatic endocrine neoplasms.
Nasir A; Helm J; Turner L; Chen DT; Strosberg J; Hafez N; Henderson-Jackson EB; Hodul P; Bui MM; Nasir NA; Hakam A; Malafa MP; Yeatman TJ; Coppola D; Kvols LK
Pancreas; 2011 May; 40(4):627-33. PubMed ID: 21499216
[TBL] [Abstract][Full Text] [Related]
7. MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
Xin W; Yun KJ; Ricci F; Zahurak M; Qiu W; Su GH; Yeo CJ; Hruban RH; Kern SE; Iacobuzio-Donahue CA
Clin Cancer Res; 2004 Dec; 10(24):8516-20. PubMed ID: 15623633
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray.
Johnson SK; Dennis RA; Barone GW; Lamps LW; Haun RS
Mol Carcinog; 2006 Nov; 45(11):814-27. PubMed ID: 16865675
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-independent gene expression mediated by SOX9 promotes aggressive pancreatic tumor biology.
Camaj P; Jäckel C; Krebs S; De Toni EN; Blum H; Jauch KW; Nelson PJ; Bruns CJ
Mol Cancer Res; 2014 Mar; 12(3):421-32. PubMed ID: 24302456
[TBL] [Abstract][Full Text] [Related]
10. Zonal heterogeneity for gene expression in human pancreatic carcinoma.
Nakamura T; Kuwai T; Kitadai Y; Sasaki T; Fan D; Coombes KR; Kim SJ; Fidler IJ
Cancer Res; 2007 Aug; 67(16):7597-604. PubMed ID: 17699763
[TBL] [Abstract][Full Text] [Related]
11. [Construction and primary application of oligonucleotide microarray specialized for pancreatic adenocarcinoma-associated genes].
Shi X; Wei WJ; Gao NR; Cheng ZJ; Tang YH
Zhonghua Wai Ke Za Zhi; 2007 Jan; 45(1):39-42. PubMed ID: 17403288
[TBL] [Abstract][Full Text] [Related]
12. CEACAM1 expression in pancreatic endocrine tumors.
Serra S; Asa SL; Bamberger AM; Wagener C; Chetty R
Appl Immunohistochem Mol Morphol; 2009 Jul; 17(4):286-93. PubMed ID: 19349857
[TBL] [Abstract][Full Text] [Related]
13. Loss of membrane localization and aberrant nuclear E-cadherin expression correlates with invasion in pancreatic endocrine tumors.
Chetty R; Serra S; Asa SL
Am J Surg Pathol; 2008 Mar; 32(3):413-9. PubMed ID: 18300809
[TBL] [Abstract][Full Text] [Related]
14. Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells.
Di Florio A; Capurso G; Milione M; Panzuto F; Geremia R; Delle Fave G; Sette C
Endocr Relat Cancer; 2007 Mar; 14(1):111-24. PubMed ID: 17395980
[TBL] [Abstract][Full Text] [Related]
15. Microarray analysis of gene expression profile of multidrug resistance in pancreatic cancer.
Zhao YP; Chen G; Feng B; Zhang TP; Ma EL; Wu YD
Chin Med J (Engl); 2007 Oct; 120(20):1743-52. PubMed ID: 18028764
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
Zhang T; Sun HC; Xu Y; Zhang KZ; Wang L; Qin LX; Wu WZ; Liu YK; Ye SL; Tang ZY
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8557-63. PubMed ID: 16361537
[TBL] [Abstract][Full Text] [Related]
17. Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
Fjällskog ML; Lejonklou MH; Oberg KE; Eriksson BK; Janson ET
Clin Cancer Res; 2003 Apr; 9(4):1469-73. PubMed ID: 12684421
[TBL] [Abstract][Full Text] [Related]
18. Characterization of gene expression profiles in intraductal papillary-mucinous tumors of the pancreas.
Terris B; Blaveri E; Crnogorac-Jurcevic T; Jones M; Missiaglia E; Ruszniewski P; Sauvanet A; Lemoine NR
Am J Pathol; 2002 May; 160(5):1745-54. PubMed ID: 12000726
[TBL] [Abstract][Full Text] [Related]
19. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis.
Missiaglia E; Blaveri E; Terris B; Wang YH; Costello E; Neoptolemos JP; Crnogorac-Jurcevic T; Lemoine NR
Int J Cancer; 2004 Oct; 112(1):100-12. PubMed ID: 15305381
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of tropomysin-related kinase B in metastatic human pancreatic cancer cells.
Sclabas GM; Fujioka S; Schmidt C; Li Z; Frederick WA; Yang W; Yokoi K; Evans DB; Abbruzzese JL; Hess KR; Zhang W; Fidler IJ; Chiao PJ
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):440-9. PubMed ID: 15701826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
